p75NTR:: A study in contrasts

被引:122
作者
Barker, PA [1 ]
机构
[1] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada
基金
英国医学研究理事会;
关键词
nerve growth factor; neurotrophins; ceramide; tumor necrosis factor; apoptosis;
D O I
10.1038/sj.cdd.4400375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p75 neurotrophin receptor (p75(NTR)) and trkA, trkB and trkC mediate the physiological effects of the neurotrophins. The trk receptors are responsible for the stereotypical survival and growth properties of the neurotrophins but defining the physiological function of the p75(NTR) has,, proven difficult. The p75(NTR) binds each of the neurotrophins with low nanomolar affinity whereas the three trk receptors show strong binding preferences for individual neurotrophins; in some cell types, p75(NTR) is the only neurotrophin receptor whereas in others it is co expressed with the trks. The analysis of p75(NTR) function has been complicated by the fact that the predominant physiological role of p75(NTR) changes dramatically depending on cell context. Available data suggests that in cells where p75(NTR) is co-expressed with trk receptors, p75(NTR) functionally collaborates with the trks to either enhance responses to preferred trk ligands, to reduce neurotrophin-mediated trk receptor activation resulting from non-preferred ligands or to facilitate apoptosis resulting from neurotrophin withdrawal. In cells lacking trk expression, p75(NTR) can act autonomously to activate ligand-dependent signaling cascades that may in some circumstances result in apoptosis but probably not through pathways utilized by its apoptotic brethren in the TNF receptor superfamily. Potential mechanisms for each of these functions of p75(NTR) are considered and the physiological implications of this unique signaling system are discussed.
引用
收藏
页码:346 / 356
页数:11
相关论文
共 142 条
  • [1] FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase
    AdamKlages, S
    Adam, D
    Wiegmann, K
    Struve, S
    Kolanus, W
    SchneiderMergener, J
    Kronke, M
    [J]. CELL, 1996, 86 (06) : 937 - 947
  • [2] ALPERS CE, 1993, LAB INVEST, V69, P703
  • [3] Baker SJ, 1996, ONCOGENE, V12, P1
  • [4] BAMJI SX, 1997, IN PRESS J CELL BIOL
  • [5] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [6] BARKER PA, 1991, J BIOL CHEM, V266, P19113
  • [7] BARKER PA, 1993, J BIOL CHEM, V268, P15150
  • [8] BARKER PA, 1994, J BIOL CHEM, V269, P30645
  • [9] DISRUPTION OF NGF BINDING TO THE LOW-AFFINITY NEUROTROPHIN RECEPTOR P75(LNTR) REDUCES NGF BINDING TO TRKA ON PC12 CELLS
    BARKER, PA
    SHOOTER, EM
    [J]. NEURON, 1994, 13 (01) : 203 - 215
  • [10] BARKER PA, 1995, ANN M SOC NEUR ABSTR